发明名称 |
Solid pharmaceutical dosage form |
摘要 |
A solid pharmaceutical dosage form providing improved oral bioavailability is disclosed for inhibitors of HIV protease. In particular, the dosage form comprises a solid dispersion of at least one HIV protease inhibitor and at least one pharmaceutically acceptable water-soluble polymer and at least one pharmaceutically acceptable surfactant, said pharmaceutically acceptable water-soluble polymer having a Tg of at least about 50° C. Preferably, the pharmaceutically acceptable surfactant has an HLB value of from about 4 to about 10.
|
申请公布号 |
US2005084529(A1) |
申请公布日期 |
2005.04.21 |
申请号 |
US20040925442 |
申请日期 |
2004.08.25 |
申请人 |
ROSENBERG JOERG;REINHOLD ULRICH;LIEPOLD BERND;BERNDL GUNTHER;BREITENBACH JORG;ALANI LAMAN L.;GHOSH SOUMOJEET |
发明人 |
ROSENBERG JOERG;REINHOLD ULRICH;LIEPOLD BERND;BERNDL GUNTHER;BREITENBACH JORG;ALANI LAMAN L.;GHOSH SOUMOJEET |
分类号 |
A61K9/16;A61K9/20;A61K31/427;A61K31/513;(IPC1-7):A61K31/513 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|